Carvedilol - A new dimension in pediatric heart failure therapy

Journal of Pediatrics

Volumn 138, Issue 4, 2001, Pages 457-458

  Spicer, Robert L ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL;

APOPTOSIS; BETA ADRENERGIC STIMULATION; CHILDHOOD DISEASE; EDITORIAL; HEART FAILURE; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0035054106     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2001.114027     Document Type: Article

References (23)

1. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy
2. Beta-adrenergic blocking drugs
3. Consensus recommendations for the management of chronic heart failure
4. Augmentation of the plasma norepinephrine response to exercise in patients with congestive heart failure
5. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure
6. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure
7. Ventricular dysfunction and necrosis produced by adrenochrome metabolite of epinephrine: Relation to pathogenesis of catecholamine cardiomyopathy
8. Adrenergic effects on the biology of the adult mammalian cardiocyte
9. Apoptotic cell death in heart failure
10. Medical therapy can improve the biologic properties of the chronically failing heart
11. Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure
12. Prospective, randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms, exercise, ejection fraction, and oxidative stress in heart failure
13. Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure
14. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure
15. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
16. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure
17. Carvedilol as therapy in pediatric heart failure: An initial multicenter experience
18. Carvedilol
19. Carvedilol, a novel multiple action antihypertensive agent with antioxidant activity and the potential for myocardial and vascular protection
20. Congestive heart failure induces endothelial cell apoptosis: Protective role of carvedilol
21. The registry of the International Society of Heart and Lung Transplantation: Third Official Pediatric Report-1999
22. Comparison of vasopep6dase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial
23. 2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure